164 related articles for article (PubMed ID: 24406455)
1. Treatment with anti-TNF alpha protects against the neuropathy induced by the proteasome inhibitor bortezomib in a mouse model.
Alé A; Bruna J; Morell M; van de Velde H; Monbaliu J; Navarro X; Udina E
Exp Neurol; 2014 Mar; 253():165-73. PubMed ID: 24406455
[TBL] [Abstract][Full Text] [Related]
2. Neurophysiological, histological and immunohistochemical characterization of bortezomib-induced neuropathy in mice.
Bruna J; Udina E; Alé A; Vilches JJ; Vynckier A; Monbaliu J; Silverman L; Navarro X
Exp Neurol; 2010 Jun; 223(2):599-608. PubMed ID: 20188093
[TBL] [Abstract][Full Text] [Related]
3. Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats.
Meregalli C; Canta A; Carozzi VA; Chiorazzi A; Oggioni N; Gilardini A; Ceresa C; Avezza F; Crippa L; Marmiroli P; Cavaletti G
Eur J Pain; 2010 Apr; 14(4):343-50. PubMed ID: 19695912
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of pre-existing neuropathy and bortezomib retreatment as risk factors to develop severe neuropathy in a mouse model.
Bruna J; Alé A; Velasco R; Jaramillo J; Navarro X; Udina E
J Peripher Nerv Syst; 2011 Sep; 16(3):199-212. PubMed ID: 22003935
[TBL] [Abstract][Full Text] [Related]
5. TNF-α-mediated JNK activation in the dorsal root ganglion neurons contributes to Bortezomib-induced peripheral neuropathy.
Zhang J; Su YM; Li D; Cui Y; Huang ZZ; Wei JY; Xue Z; Pang RP; Liu XG; Xin WJ
Brain Behav Immun; 2014 May; 38():185-91. PubMed ID: 24530998
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy.
Meregalli C; Chiorazzi A; Carozzi VA; Canta A; Sala B; Colombo M; Oggioni N; Ceresa C; Foudah D; La Russa F; Miloso M; Nicolini G; Marmiroli P; Bennett DL; Cavaletti G
Cell Cycle; 2014; 13(4):612-21. PubMed ID: 24335344
[TBL] [Abstract][Full Text] [Related]
7. The neuroprotective effect of tropisetron on vincristine-induced neurotoxicity.
Barzegar-Fallah A; Alimoradi H; Mehrzadi S; Barzegar-Fallah N; Zendedel A; Abbasi A; Dehpour AR
Neurotoxicology; 2014 Mar; 41():1-8. PubMed ID: 24374478
[TBL] [Abstract][Full Text] [Related]
8. Mitotoxicity and bortezomib-induced chronic painful peripheral neuropathy.
Zheng H; Xiao WH; Bennett GJ
Exp Neurol; 2012 Dec; 238(2):225-34. PubMed ID: 22947198
[TBL] [Abstract][Full Text] [Related]
9. Bortezomib-induced peripheral neurotoxicity: a neurophysiological and pathological study in the rat.
Cavaletti G; Gilardini A; Canta A; Rigamonti L; Rodriguez-Menendez V; Ceresa C; Marmiroli P; Bossi M; Oggioni N; D'Incalci M; De Coster R
Exp Neurol; 2007 Mar; 204(1):317-25. PubMed ID: 17214983
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of TRPA1 and IL-6 signal alleviates neuropathic pain following chemotherapeutic bortezomib.
Liu D; Sun M; Xu D; Ma X; Gao D; Yu H
Physiol Res; 2019 Oct; 68(5):845-855. PubMed ID: 31424261
[TBL] [Abstract][Full Text] [Related]
11. Transient early expression of TNF-alpha in sciatic nerve and dorsal root ganglia in a mouse model of painful peripheral neuropathy.
Sacerdote P; Franchi S; Trovato AE; Valsecchi AE; Panerai AE; Colleoni M
Neurosci Lett; 2008 May; 436(2):210-3. PubMed ID: 18394803
[TBL] [Abstract][Full Text] [Related]
12. The Proteasome Inhibitor Bortezomib Inhibits Inflammatory Response of Periodontal Ligament Cells and Ameliorates Experimental Periodontitis in Rats.
Jiang L; Song J; Hu X; Zhang H; Huang E; Zhang Y; Deng F; Wu X
J Periodontol; 2017 May; 88(5):473-483. PubMed ID: 27982724
[TBL] [Abstract][Full Text] [Related]
13. Proteasome inhibition aggravates tumor necrosis factor-mediated bone resorption in a mouse model of inflammatory arthritis.
Polzer K; Neubert K; Meister S; Frey B; Baum W; Distler JH; Gückel E; Schett G; Voll RE; Zwerina J
Arthritis Rheum; 2011 Mar; 63(3):670-80. PubMed ID: 21360496
[TBL] [Abstract][Full Text] [Related]
14. Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies.
Carozzi VA; Canta A; Oggioni N; Sala B; Chiorazzi A; Meregalli C; Bossi M; Marmiroli P; Cavaletti G
Exp Neurol; 2010 Dec; 226(2):301-9. PubMed ID: 20832406
[TBL] [Abstract][Full Text] [Related]
15. The proteasome inhibitor bortezomib aggravates renal ischemia-reperfusion injury.
Huber JM; Tagwerker A; Heininger D; Mayer G; Rosenkranz AR; Eller K
Am J Physiol Renal Physiol; 2009 Aug; 297(2):F451-60. PubMed ID: 19458122
[TBL] [Abstract][Full Text] [Related]
16. Antibody against tumor necrosis factor-α reduces bortezomib-induced allodynia in a rat model.
Chiorazzi A; Canta A; Meregalli C; Carozzi V; Sala B; Oggioni N; Monbaliu J; VAN DE Velde H; Cavaletti G
Anticancer Res; 2013 Dec; 33(12):5453-9. PubMed ID: 24324081
[TBL] [Abstract][Full Text] [Related]
17. Pathological adaptive responses of Schwann cells to endoplasmic reticulum stress in bortezomib-induced peripheral neuropathy.
Shin YK; Jang SY; Lee HK; Jung J; Suh DJ; Seo SY; Park HT
Glia; 2010 Dec; 58(16):1961-76. PubMed ID: 20830808
[TBL] [Abstract][Full Text] [Related]
18. Exercise training attenuates neuropathic pain and cytokine expression after chronic constriction injury of rat sciatic nerve.
Chen YW; Li YT; Chen YC; Li ZY; Hung CH
Anesth Analg; 2012 Jun; 114(6):1330-7. PubMed ID: 22415536
[TBL] [Abstract][Full Text] [Related]
19. Hyperbaric oxygenation therapy alleviates chronic constrictive injury-induced neuropathic pain and reduces tumor necrosis factor-alpha production.
Li F; Fang L; Huang S; Yang Z; Nandi J; Thomas S; Chen C; Camporesi E
Anesth Analg; 2011 Sep; 113(3):626-33. PubMed ID: 21596875
[TBL] [Abstract][Full Text] [Related]
20. Immune-mediated neuropathies in myeloma patients treated with bortezomib.
Ravaglia S; Corso A; Piccolo G; Lozza A; Alfonsi E; Mangiacavalli S; Varettoni M; Zappasodi P; Moglia A; Lazzarino M; Costa A
Clin Neurophysiol; 2008 Nov; 119(11):2507-12. PubMed ID: 18829381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
